文献速递肝病消化内镜

超声内镜引导下肝脏触诊作为疑似代谢功能障碍相关脂肪性肝病患者进展期纤维化和肝硬化筛查工具的初步研究

EUS-guided liver palpation as a screening tool for advanced fibrosis and cirrhosis in patients with suspected metabolic dysfunction-associated steatotic liver disease: a pilot study.
PubMed 文献 · Gastrointest Endosc · 2024-02-29

这项横断面初步研究在3家医院连续纳入73例疑似代谢功能障碍相关脂肪性肝病患者,行超声内镜引导下肝脏触诊并对照肝活检,比较其与FIB-4、APRI、NFS及瞬时弹性成像预测纤维化分期的效能。触诊压痕深度与纤维化分期负相关,判别进展期纤维化和肝硬化的c-statistic分别为0.79和0.95,在预测进展期纤维化上优于NFS,在预测肝硬化上优于APRI、NFS和瞬时弹性成像,与FIB-4无显著差异。

要点

  • 压痕深度与纤维化分期负相关(Kruskal-Wallis检验,P<.0001)。
  • 判别进展期纤维化和肝硬化的c-statistic分别为0.79和0.95。
  • 压痕≤3.5 mm对进展期纤维化有100%阳性预测值,≥4.0 mm对排除肝硬化有100%阴性预测值。

核心结论

  • 超声内镜引导下肝脏触诊是一种新颖、准确且易于使用的筛查工具,可用于代谢功能障碍相关脂肪性肝病患者的进展期纤维化和肝硬化筛查。

研究设计与样本

  • 这是一项横断面初步研究,2021年至2023年在3家医院连续纳入73例疑似代谢功能障碍相关脂肪性肝病患者,行超声内镜引导下肝脏触诊并对照肝活检。
  • 将肝脏触诊与FIB-4、APRI、NFS及瞬时弹性成像预测组织学纤维化分期进行比较,并进行受试者工作特征曲线下面积分析。

主要发现

  • 患者平均年龄49.1岁,女性占71.2%,平均体重指数41.1 kg/m²。
  • 压痕深度与纤维化分期负相关(Kruskal-Wallis检验,P<.0001)。
  • 超声内镜触诊判别进展期纤维化和肝硬化的c-statistic分别为0.79和0.95。
  • 超声内镜肝脏触诊在预测进展期纤维化上优于NFS(P=.0057),在预测肝硬化上优于APRI(P=.0099)和NFS(P=.045)。
  • 超声内镜触诊与FIB-4无显著差异;在预测肝硬化上优于瞬时弹性成像(P=.045)。

关键数值与推荐

  • 采用最佳截断值时,压痕测量≤3.5 mm对进展期纤维化有100%阳性预测值,≥4.0 mm对排除肝硬化有100%阴性预测值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Endoscopic liver "palpation" can be performed by indenting the liver surface under EUS. Indentation depth is measured with the use of sonographic calipers. We hypothesized that fibrotic livers are more difficult to indent, and that indentation can accurately predict liver fibrosis staging. We compared EUS-guided liver palpation and conventional screening modalities in patients with suspected metabolic dysfunction-associated steatotic liver disease. METHODS: This was a cross-sectional pilot study. Consecutive patients at 3 hospitals from 2021 to 2023 underwent EUS-guided palpation with liver biopsy. Liver palpation was compared with fibrosis-4 index (FIB-4), aspartate transaminase to platelet ratio index (APRI), nonalcoholic fatty liver disease fibrosis score (NFS), and transient elastography in predicting fibrosis staging on histology. Area under the receiver operating characteristic curve analysis was performed. RESULTS: Seventy-three patients were included. Mean age was 49.1 years, and 71.2% were female. Mean body mass index was 41.1 kg/m.2 Indentation depth was negatively correlated with fibrosis stage (Kruskal-Willis test, P < .0001). EUS palpation demonstrated c-statistics of 0.79 and 0.95 in discriminating advanced fibrosis and cirrhosis, respectively. EUS liver palpation was superior to NFS in predicting advanced fibrosis (P = .0057) and superior to APRI and NFS in predicting cirrhosis (P = .0099 and P = .045, respectively). EUS palpation was not significantly different from FIB-4. EUS palpation was superior to transient elastography in predicting cirrhosis (P = .045). When optimal cutoffs were used, indentation measurement ≤3.5 mm yielded 100% predictive value for ruling in advanced fibrosis, and ≥4.0 mm yielded 100% predictive value for ruling out cirrhosis. CONCLUSIONS: EUS liver palpation is a novel, accurate, and easy-to-use screening tool for advanced fibrosis and cirrhosis in patients with metabolic dysfunction-associated steatotic liver disease.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Wang TJ, Jirapinyo P, Shah R, et al. EUS-guided liver palpation as a screening tool for advanced fibrosis and cirrhosis in patients with suspected metabolic dysfunction-associated steatotic liver disease: a pilot study. Gastrointest Endosc. 2024. PMID: 38431106. doi:10.1016/j.gie.2024.02.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。